Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
Clinical trial NCT06540326 · RECRUITING
Trial details
- NCT number
- NCT06540326
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-12
- Primary completion
- 2026-04-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.